PEDIATRIC CLINICAL TRIALS: FROM ENCOURAGEMENT TO REGULATORY REQUIREMENTS
Prescription of a drug for children is often accompanied with failure to follow the indications, methods of administration, dosages recommended (as a rule, for adults) by product directions. The article illustrates factors that prevent the conduct of clinical trials involving children on a larger sc...
Saved in:
Main Author: | I.V. Smolenov (Author) |
---|---|
Format: | Book |
Published: |
Union of pediatricians of Russia,
2010-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PEDIATRIC CLINICAL TRIALS: FROM ENCOURAGEMENT TO REGULATORY REQUIREMENTS
by: I.V. Smolenov
Published: (2010) -
COMMENTS ON THE ARTICLE I.V. SMOLENOV «PEDIATRIC CLINICAL TRIALS: FROM ENCOURAGEMENT TO REGULATORY REQUIREMENTS»
by: S.S. Zavidova
Published: (2010) -
COMMENTS ON THE ARTICLE I.V. SMOLENOV «PEDIATRIC CLINICAL TRIALS: FROM ENCOURAGEMENT TO REGULATORY REQUIREMENTS»
by: S.S. Zavidova
Published: (2010) -
Requirements for Transparency and Communicability of Regulatory Science
by: A. Alan Moghissi, et al.
Published: (2018) -
Japan regulatory requirements for variation procedures and GMP inspection
by: V. Santosh Kumar, et al.
Published: (2012)